Nephrocare IPO Subscription Status: Nephrocare IPO is Open on 28 June, 2024 and Close on 2 July, 2024. Nephrocare IPO to Raise 45,84,000 shares (Approx ₹41.26 Cr) via IPO. The Fresh issue of 45,84,000 Shares (Approx ₹41.26 Cr).
- The Retail Quota is 35%
- QIB is 50%
- NII is 15%
The Nephrocare IPO is an SME IPO and Listed on NSE SME. Nephrocare IPO Price Band is Fixed at ₹90 Equity Share. Nephrocare IPO Lot Size is 1600 Shares.
About Nephrocare IPO :
- Nephrocare was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.
- The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure. At Nephro Care treatment regimes are planned and practiced on the basis of core scientific understanding, transparency and ethics. We are committed to providing the best medical care at an affordable cost to all our local, national and international patients.
- Our vision is to reach out to the masses through a holistic approach combining modern medicine with time tested yogic wisdom to touch the lives of one million kidney disease patients across the country by leveraging our hub-and-spoke model. We have a wide spec of diagnostic facilities to provide our doctors freedom to explore all diagnostic possibilities and offer our patients a better service and care under one roof and to also ensure optimum clinical outcomes.
Nephrocare IPO Subscription Status, Rate bid times
| Inv Category | Shares Reserved | No. of Shares bid for | No. of Times (Subscription) |
|---|---|---|---|
| Qualified Buyers (QIBs) | 8,25,600 | 20,23,87,200 | 245.14 |
| Non Institutional Buyers (NIIs) | 6,19,200 | 1,10,66,25,600 | 1,787.19 |
| Retail Individual Buyers (RIIs) | 14,44,800 | 91,61,77,600 | 634.12 |
| Anchor Investor | 12,38,400 | 12,38,400 | 1 |
| Market Maker | 2,30,400 | 2,30,400 | 1 |
| Total | 31,15,200 | 2,22,98,01,600 | 715.80 |
Nephrocare Subscription Status day-by-day-
| Categories | 28 June | 1 July | 2 July |
|---|---|---|---|
| QIB | 0.09 | 2.68 | 245.14 |
| NII | 14.13 | 206.07 | 1,787.19 |
| RII | 30.20 | 210.48 | 634.14 |
| Total | 16.84 | 139.30 | 715.80 |
The Nephrocare Investor Categories
- Qualified Institutional Buyers (QIB).
- Non- Institutional Investors (NII).
- Retail individual Investors (RII).
- Employee (EMP).
- Others (Eligible Shareholders).
Who Is QIB In IPO?
QIB Stands For “Qualified Institutional Buyer” In The Context Of An IPO (Initial Public Offering). In The Context Of An IPO, QIBs Play A Significant Role As They Contribute To The Overall Demand For Shares And Help Determine The Success Of The Offering.
Who Is NII In IPO?
NII Stands For “Non-Institutional Investors” In The Context Of An IPO (Initial Public Offering). Non-Institutional Investors Are A Category Of Investors Who Participate In The IPO Alongside Institutional Investors And Retail Investors. NII Typically Includes High Net Worth Individuals (HNIs), Corporate Bodies, Trusts, And Other Entities That Are Not Classified As Institutional Investors But Have The Financial Capacity To Invest Significant Amounts In The IPO.
Who Is RII In IPO?
RII Stands For “Retail Individual Investor” In The Context Of An IPO (Initial Public Offering). Retail Individual Investors Are Individual Investors Who Participate In The IPO Alongside Institutional Investors And Non-Institutional Investors. RII Typically Includes Individual Investors Who Do Not Meet The Criteria To Be Classified As Institutional Investors Or Non-Institutional Investors.
Who Is EMP In IPO?
“EMP” In The Context Of An IPO (Initial Public Offering) Typically Stands For “Employee.”
Nephrocare Review From MoneyMintIdea –
- May Apply
